CLINICAL_TRIALS
trial_result
· 2023-08-07
Clinical Trial Update: Cysteamine Compared to Hydroquinone in Melasma [Phase 3]
Summary
A Phase 3 trial comparing cysteamine to hydroquinone in the treatment of melasma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: China Medical University Hospital | Conditions: Melasma | Phase 3 | Status: COMPLETED